Zobrazeno 1 - 10
of 148
pro vyhledávání: '"Heart Failure/blood"'
Autor:
Jens Faber, Jesper Jensen, Mariam Elmegaard Malik, Christian Tuxen, Lars Thorbjørn Jensen, Lars Køber, Niels Eske Bruun, Morten Schou, Ida Gustafsson, Emil L. Fosbøl, Finn Gustafsson, Caroline Kistorp, Julie Lyng Forman, Massar Omar, Jacob E. Møller
Publikováno v:
Jensen, J, Omar, M, Kistorp, C, Tuxen, C, Gustafsson, I, Køber, L, Gustafsson, F, Faber, J, Malik, M E, Fosbøl, E L, Bruun, N E, Forman, J L, Jensen, L T, Møller, J E & Schou, M 2021, ' Effects of empagliflozin on estimated extracellular volume, estimated plasma volume, and measured glomerular filtration rate in patients with heart failure (Empire HF Renal) : a prespecified substudy of a double-blind, randomised, placebo-controlled trial ', The Lancet Diabetes & Endocrinology, vol. 9, no. 2, pp. 106-116 . https://doi.org/10.1016/S2213-8587(20)30382-X
Jensen, J, Omar, M, Kistorp, C, Tuxen, C, Gustafsson, I, Køber, L, Gustafsson, F, Faber, J, Malik, M E, Fosbøl, E L, Bruun, N E, Forman, J L, Jensen, L T, Møller, J E & Schou, M 2021, ' Effects of empagliflozin on estimated extracellular volume, estimated plasma volume, and measured glomerular filtration rate in patients with heart failure (Empire HF Renal) : a prespecified substudy of a double-blind, randomised, placebo-controlled trial ', The Lancet Diabetes and Endocrinology, vol. 9, no. 2, pp. 106-116 . https://doi.org/10.1016/S2213-8587(20)30382-X
Jensen, J, Omar, M, Kistorp, C, Tuxen, C, Gustafsson, I, Køber, L, Gustafsson, F, Faber, J, Malik, M E, Fosbøl, E L, Bruun, N E, Forman, J L, Jensen, L T, Møller, J E & Schou, M 2021, ' Effects of empagliflozin on estimated extracellular volume, estimated plasma volume, and measured glomerular filtration rate in patients with heart failure (Empire HF Renal) : a prespecified substudy of a double-blind, randomised, placebo-controlled trial ', The Lancet Diabetes and Endocrinology, vol. 9, no. 2, pp. 106-116 . https://doi.org/10.1016/S2213-8587(20)30382-X
BACKGROUND: SGLT2 inhibitors are a promising treatment option in patients with heart failure and reduced ejection fraction. We aimed to investigate the effects of empagliflozin on estimated extracellular volume, estimated plasma volume, and measured
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c49fee5041679414e31800f12e9b4f4d
https://doi.org/10.1016/s2213-8587(20)30382-x
https://doi.org/10.1016/s2213-8587(20)30382-x
Autor:
Steffen Blum, Stefanie Aeschbacher, Pascal Meyre, Michael Kühne, Nicolas Rodondi, Jürg H. Beer, Peter Ammann, Giorgio Moschovitis, Leo H. Bonati, Manuel R. Blum, Peter Kastner, Fiona Baguley, Christian Sticherling, Stefan Osswald, David Conen, Chloé Auberson, Leo Bonati, Selinda Ceylan, Simone Doerpfeld, Ceylan Eken, Marc Girod, Peter Hämmerle, Philipp Krisai, Christine Meyer-Zürn, Andreas U. Monsch, Christian Müller, Anne Springer, Thomas Szucs, Gian Voellmin, Leon Zwimpfer, Drahomir Aujesky, Urs Fischer, Juerg Fuhrer, Laurent Roten, Simon Jung, Heinrich Mattle, Luise Adam, Carole Elodie Aubert, Martin Feller, Axel Loewe, Elisavet Moutzouri, Claudio Schneider, Tanja Flückiger, Cindy Groen, Lukas Ehrsam, Sven Hellrigl, Alexandra Nuoffer, Damiana Rakovic, Nathalie Schwab, Rylana Wenger, Christopher Beynon, Roger Dillier, Michèle Deubelbeiss, Franz Eberli, Christine Franzini, Isabel Juchli, Claudia Liedtke, Jacqueline Nadler, Thayze Obst, Jasmin Roth, Fiona Schlomowitsch, Xiaoye Schneider, Katrin Studerus, Noreen Tynan, Dominik Weishaupt, Andreas Müller, Simone Fontana, Silke Kuest, Karin Scheuch, Denise Hischier, Nicole Bonetti, Alexandra Grau, Jonas Villinger, Eva Laube, Philipp Baumgartner, Mark Filipovic, Marcel Frick, Giulia Montrasio, Stefanie Leuenberger, Franziska Rutz, Jürg-Hans Beer, Angelo Auricchio, Adriana Anesini, Cristina Camporini, Giulio Conte, Maria Luce Caputo, Francois Regoli, Tiziano Moccetti, Roman Brenner, David Altmann, Michaela Gemperle, Mathieu Firmann, Sandrine Foucras, Martine Rime, Daniel Hayoz, Benjamin Berte, Virgina Justi, Frauke Kellner-Weldon, Brigitta Mehmann, Sonja Meier, Myriam Roth, Andrea Ruckli-Kaeppeli, Ian Russi, Kai Schmidt, Mabelle Young, Melanie Zbinden, Richard Kobza, Jane Frangi-Kultalahti, Anica Pin, Luisa Vicari, Georg Ehret, Hervé Gallet, Elise Guillermet, Francois Lazeyras, Karl-Olof Lovblad, Patrick Perret, Philippe Tavel, Cheryl Teres, Dipen Shah, Nathalie Lauriers, Marie Méan, Sandrine Salzmann, Jürg Schläpfer, Andrea Grêt, Jan Novak, Sandra Vitelli, Frank-Peter Stephan, Augusto Gallino, Marcello Di Valentino, Fabienne Witassek, Matthias Schwenkglenks, Jens Würfel, Anna Altermatt, Michael Amann, Petra Huber, Esther Ruberte, Tim Sinnecker, Vanessa Zuber, Michael Coslovsky, Pascal Benkert, Gilles Dutilh, Milica Markovic, Patrick Simon, Ramun Schmid
Publikováno v:
Heart Rhythm, Vol. 18, No 4 (2021) pp. 512-519
BACKGROUND: The occurrence of congestive heart failure (CHF) hospitalization among patients with atrial fibrillation (AF) is a poor prognostic marker. OBJECTIVE: The purpose of this study was to assess whether insulin-like growth factor-binding prote
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf07f5d003723f8745fc92a0cdac9eb3
https://pubmed.ncbi.nlm.nih.gov/33278630
https://pubmed.ncbi.nlm.nih.gov/33278630
Autor:
Iziah E Sama, Piotr Ponikowski, Stefan D. Anker, Dirk J. van Veldhuisen, Alice Ravera, John G.F. Cleland, Michiel Rienstra, Leong L. Ng, Gerasimos Filippatos, Kenneth Dickstein, Jozine M. ter Maaten, Chim C. Lang, Bernadet T. Santema, Adriaan A. Voors, Marco Metra, Harry van Goor, Alexander W. Friedrich, Nilesh J. Samani
Publikováno v:
European Heart Journal, 41(19), 1810-1817. Oxford University Press
European Heart Journal
European Heart Journal
Aims The current pandemic coronavirus SARS-CoV-2 infects a wide age group but predominantly elderly individuals, especially men and those with cardiovascular disease. Recent reports suggest an association with use of renin–angiotensin–aldosterone
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f37ee3fee79f31cf309c180cd4fac1f4
http://hdl.handle.net/11379/532024
http://hdl.handle.net/11379/532024
Autor:
Michael R. Zile, Jean L. Rouleau, Akshay S. Desai, Margaret F. Prescott, Karl Swedberg, Pardeep S. Jhund, Milton Packer, Paul Welsh, Rasmus Rørth, Scott D. Solomon, Mehmet Yilmaz, Søren Lund Kristensen, Lars Køber, John J.V. McMurray
Publikováno v:
Rørth, R, Jhund, P S, Yilmaz, M B, Kristensen, S L, Welsh, P, Desai, A S, Køber, L, Prescott, M F, Rouleau, J L, Solomon, S D, Swedberg, K, Zile, M R, Packer, M & McMurray, J J V 2020, ' Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction ', Circulation. Heart failure, vol. 13, no. 2, e006541 . https://doi.org/10.1161/CIRCHEARTFAILURE.119.006541
Background: Both BNP (B-type natriuretic peptide) and NT-proBNP (N-terminal pro B-type natriuretic peptide) are widely used to aid diagnosis, assess the effect of therapy, and predict outcomes in heart failure and reduced ejection fraction. However,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09421e2f86be9222dda767f6e81c3cbd
https://curis.ku.dk/ws/files/290450091/Comparison_of_BNP_and_NT_proBNP_in_patients_with_heart_failure_and.pdf
https://curis.ku.dk/ws/files/290450091/Comparison_of_BNP_and_NT_proBNP_in_patients_with_heart_failure_and.pdf
Autor:
Burkert, Pieske, Mahesh J, Patel, Cynthia M, Westerhout, Kevin J, Anstrom, Javed, Butler, Justin, Ezekowitz, Adrian F, Hernandez, Joerg, Koglin, Carolyn S P, Lam, Piotr, Ponikowski, Lothar, Roessig, Adriaan A, Voors, Christopher M, O'Connor, Paul W, Armstrong, Jian, Zhang
Publikováno v:
Pieske, B, Patel, M J, Westerhout, C M, Anstrom, K J, Butler, J, Ezekowitz, J, Hernandez, A F, Koglin, J, Lam, C S P, Ponikowski, P, Roessig, L, Voors, A A, O'Connor, C M, Armstrong, P W & VICTORIA Study Group 2019, ' Baseline features of the VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction) trial ', European Journal of Heart Failure, vol. 21, no. 12, pp. 1596-1604 . https://doi.org/10.1002/ejhf.1664
European Journal of Heart Failure
European Journal of Heart Failure, 2019, 21 (12), pp.1596-1604. ⟨10.1002/ejhf.1664⟩
European Journal of Heart Failure, 21(12), 1596-1604. Wiley
European Journal of Heart Failure
European Journal of Heart Failure, 2019, 21 (12), pp.1596-1604. ⟨10.1002/ejhf.1664⟩
European Journal of Heart Failure, 21(12), 1596-1604. Wiley
International audience; Aim: Describe the distinguishing features of heart failure (HF) patients with reduced ejection fraction (HFrEF) in the VICTORIA (Vericiguat Global Study in Patients with Heart Failure with Reduced Ejection Fraction) trial.Meth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64c0559faf46b4ff186b6cd3dfba3f3e
https://pure.au.dk/portal/da/publications/baseline-features-of-the-victoria-vericiguat-global-study-in-subjects-with-heart-failure-with-reduced-ejection-fraction-trial(abef0460-5e68-4f8f-9aab-7efe513d1837).html
https://pure.au.dk/portal/da/publications/baseline-features-of-the-victoria-vericiguat-global-study-in-subjects-with-heart-failure-with-reduced-ejection-fraction-trial(abef0460-5e68-4f8f-9aab-7efe513d1837).html
Publikováno v:
Esc heart failure. 5(3):240-248
AimsMethods to identify patients at risk for incident HF would be welcome as such patients might benefit from earlier interventions. Methods and resultsFrom a registry of 1251 patients referred for coronary and/or peripheral angiography, we sought to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dris___00893::6ccdeb93b39991f8ca2311f5edb3f975
https://doi.org/10.1002/ehf2.12268
https://doi.org/10.1002/ehf2.12268
Publikováno v:
European Journal of Heart Failure. 19(5):643-649
Aims: Pharmacological therapies for heart failure (HF) aim to improve congestion, symptoms, and prognosis. Failing to take medication is a potential cause of worsening HF. Characterizing the effects of short-term medication omission could inform the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dris___01180::338c377ff952da9987476dd958dc0310
https://research.tue.nl/en/publications/e08b3e34-eed6-4b36-812f-723dda8d9b63
https://research.tue.nl/en/publications/e08b3e34-eed6-4b36-812f-723dda8d9b63
Autor:
Matthias Dupont, Frederik H. Verbrugge, W.H. Wilson Tang, Wilfried Mullens, Petra Nijst, Pieter Martens
Publikováno v:
The American Journal of Cardiology. 119:65-70
Iron deficiency is prevalent in heart failure with reduced ejection fraction and relates to symptomatic status, readmission, and all-cause mortality. The relation between iron status and response to cardiac resynchronization therapy (CRT) remains ins
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5558cdc17dc8b6facd91002c04bd5539
https://doi.org/10.1016/j.amjcard.2016.09.017
https://doi.org/10.1016/j.amjcard.2016.09.017
Autor:
W.H. Wilson Tang, Carmen Reynders, Matthias Dupont, Nicolas Degryse, Pieter Martens, Joris Penders, Wilfried Mullens, Kevin Damman, Frederik H. Verbrugge, Petra Nijst, Jeffrey M. Testani
Publikováno v:
JACC. Heart failure, 7(5), 404-414. ELSEVIER SCI LTD
OBJECTIVES This study sought to determine the relationship between urinary sodium (U-na) concentration and the pathophysiologic interaction with the development of acute heart failure (AHF) hospitalization.BACKGROUND No data are available on the long
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6b1bfd8929f4780c5209bd01c7d86eb
https://doi.org/10.1016/j.jchf.2019.02.011
https://doi.org/10.1016/j.jchf.2019.02.011
Autor:
Ragnvi Hagman, T. Falk, Katja Höglund, Anna Hillström, Jacob E. Møller, Jens Häggström, Ingrid Ljungvall, Lisbeth H. Olsen, M.J. Reimann
Publikováno v:
Reimann, M J, Ljungvall, I, Hillstrom, A, Moller, J E, Hagman, R, Falk, R T, Hoglund, K, Haggstrom, J & Olsen, L H 2016, ' Increased serum C-reactive protein concentrations in dogs with congestive heart failure due to myxomatous mitral valve disease ', Veterinary Journal, vol. 209, pp. 113-118 . https://doi.org/10.1016/j.tvjl.2015.12.006
Cardiovascular disease in humans and dogs is associated with mildly increased circulating concentrations of C-reactive protein (CRP). Few studies have evaluated associations between circulating CRP and canine myxomatous mitral valve disease (MMVD) an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a883de55671325bf55bb162b5d22044
https://doi.org/10.1016/j.tvjl.2015.12.006
https://doi.org/10.1016/j.tvjl.2015.12.006